Financing
Payment of Deferred Purchase Consideration
Boston Scientific Payment of Deferred Purchase Consideration decreased by 95.2% to $3.00M in Q1 2026 compared to the prior quarter.
Analysis
StatementCash Flow Statement
SectionFinancing
First reportedQ1 2018
Last reportedQ1 2026May 1, 2026
Metric ID:
isrg_payment_of_deferred_purchase_considerationHistorical Data
14 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q1 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $3.00M | $0.00 | $1.00M | $20.00M | $263.00M | $52.00M | $0.00 | $34.00M | $5.00M | $34.00M | $97.00M | $0.00 | $62.00M | $3.00M |
| QoQ Change | — | -100.0% | — | >999% | >999% | -80.2% | -100.0% | — | -85.3% | +580.0% | +185.3% | -100.0% | — | -95.2% |
| YoY Change | — | — | — | — | >999% | — | -100.0% | +70.0% | -98.1% | +0.0% | — | -100.0% | — | — |
Range$0.00 – $263.00M
CAGR+0.0%
Avg YoY Growth>999%
Median YoY Growth-49.0%
Payment of Deferred Purchase Consideration at Other Companies
Frequently Asked Questions
- What is Boston Scientific's payment of deferred purchase consideration?
- Boston Scientific (BSX) reported payment of deferred purchase consideration of $3.00M in Q1 2026.